Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor† †Electronic supplementary information (ESI) available: Supplementary figures, data and methods. See DOI: 10.1039/c8sc02634c
暂无分享,去创建一个
Oliver Werz | Francisco Corzana | Markus Werner | Gonçalo J L Bernardes | Padma Akkapeddi | Tiago Rodrigues | O. Werz | Markus Werner | A. Koeberle | T. Rodrigues | G. Bernardes | F. Corzana | P. Akkapeddi | Jakob Roth | Eduardo H G da Cruz | Marta C Marques | Susana A Lobo | Andreas Koeberle | Eufrânio N da Silva Júnior | M. Marques | E. N. da Silva Júnior | S. A. Lobo | J. Roth | Eufrânio N. da Silva Júnior
[1] J. Minna,et al. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone , 2007, Proceedings of the National Academy of Sciences.
[2] G. Schneider,et al. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo. , 2013, Journal of medicinal chemistry.
[3] Tiago Rodrigues,et al. Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point. , 2017, Organic & biomolecular chemistry.
[4] O. Werz,et al. 1-Oleoyl-2-acetylglycerol Stimulates 5-Lipoxygenase Activity via a Putative (Phospho)lipid Binding Site within the N-terminal C2-like Domain* , 2005, Journal of Biological Chemistry.
[5] Divya K. Nair,et al. Naphthoquinone-based chalcone hybrids and derivatives: synthesis and potent activity against cancer cell lines , 2015 .
[6] A. Schuffenhauer,et al. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] Judith M. LaLonde,et al. The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1 , 2013, International journal of tryptophan research : IJTR.
[8] C. K. Andrade,et al. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones. , 2008, Bioorganic & medicinal chemistry.
[9] Petra Schneider,et al. Counting on natural products for drug design. , 2016, Nature chemistry.
[10] C. Myers,et al. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] O. Werz,et al. The Aminosteroid Phospholipase C Antagonist U-73122 (1-[6-[[17-β-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) Potently Inhibits Human 5-Lipoxygenase in Vivo and in Vitro , 2005, Molecular Pharmacology.
[12] D. Steinhilber,et al. On the induction of 5-lipoxygenase expression and activity in HL-60 cells: effects of vitamin D3, retinoic acid, DMSO and TGF beta. , 1994, Biochemical and biophysical research communications.
[13] Mathias Dunkel,et al. SuperPred: update on drug classification and target prediction , 2014, Nucleic Acids Res..
[14] Jinming Gao,et al. Development of β-Lapachone Prodrugs for Therapy Against Human Cancer Cells with Elevated NAD(P)H:Quinone Oxidoreductase 1 Levels , 2005, Clinical Cancer Research.
[15] G. Schneider,et al. Revealing the Macromolecular Targets of Fragment-Like Natural Products. , 2015, Angewandte Chemie.
[16] M. Kinch,et al. An analysis of FDA-approved drugs: natural products and their derivatives. , 2016, Drug discovery today.
[17] Petra Schneider,et al. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus , 2014, Proceedings of the National Academy of Sciences.
[18] D. Newman,et al. Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.
[19] Herbert Waldmann,et al. Natural product inspired compound collections: evolutionary principle, chemical synthesis, phenotypic screening, and target identification. , 2017, Drug discovery today. Technologies.
[20] Francisco Corzana,et al. Unveiling (−)‐Englerin A as a Modulator of L‐Type Calcium Channels , 2016, Angewandte Chemie.
[21] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[22] B. Persson,et al. A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activity. , 2014, Archives of biochemistry and biophysics.
[23] Diana Murray,et al. Molecular Basis of the Specific Subcellular Localization of the C2-like Domain of 5-Lipoxygenase* , 2002, The Journal of Biological Chemistry.
[24] A. Harvey,et al. The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.
[25] M. O. Moraes,et al. Synthesis and potent antitumor activity of new arylamino derivatives of nor-β-lapachone and nor-α-lapachone , 2007 .
[26] Petra Schneider,et al. Revealing the macromolecular targets of complex natural products. , 2014, Nature chemistry.
[27] Petra Schneider,et al. Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for ‘Orphan’ Molecules , 2013, Molecular informatics.
[28] G. Schneider,et al. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. , 2016, Angewandte Chemie.
[29] E. Tremoli,et al. 5-Lipoxygenase gene expression in HL60 cells during differentiation with DMSO. , 1993, Pharmacological research.
[30] R. Glen,et al. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.
[31] Thierry Langer,et al. In silico Target Fishing for Rationalized Ligand Discovery Exemplified on Constituents of Ruta graveolens , 2008, Planta medica.